Diagnostics & Research
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Agilent Technologies, Inc. Diagnostics & Research A$177.49 64 Health 64 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Waters Corporation Diagnostics & Research WAT$468.55 64 Health 64 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Labcorp Holdings Inc. Diagnostics & Research LH$331.17 64 Health 64 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- IQVIA Holdings Inc. Diagnostics & Research IQV$271.55 58 Health 58 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Charles River Laboratories International, Inc. Diagnostics & Research CRL$358.84 57 Health 57 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- ICON Public Limited Company Diagnostics & Research ICLR$182.98 52 Health 52 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- GRAIL, Inc. Diagnostics & Research GRAL$150.61 52 Health 52 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Natera, Inc. Diagnostics & Research NTRA$410.82 45 Health 45 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Guardant Health, Inc. Diagnostics & Research GH$178.06 45 Health 45 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- GeneDx Holdings Corp. Diagnostics & Research WGS$62.74 45 Health 45 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.